BioCentury
ARTICLE | Finance

Ebb & Flow

August 28, 2006 7:00 AM UTC

Dietmar Hopp, the German business angel and billionaire co-founder of software giant SAP, has completed the first phase of his entry into the European biotech sector and is now looking to consolidate his investments. In the past four years Hopp has invested more than E200 million ($253 million) in 12 biotech and two medtech companies. Now he is preparing to earmark funds to develop two portfolio clusters - cancer and CNS diseases (see "An Angel's Collection").

"It is not our intention to just grow the number of companies in the portfolio, but instead focus on our investments and develop them further by bringing products through the pipeline into the marketplace, finding appropriate business partners and taking companies to the capital markets, achieving successful exits and then re-investing in other companies," Hopp told Ebb & Flow. ...